(Q40420609)

20 September 2017

Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). (English)

1 reference

chronic lymphocytic leukemia

20 September 2017

0 references

1 reference

Winkler D

1

1 reference

20 September 2017

Schneider C

2

1 reference

20 September 2017

Kröber A

3

1 reference

20 September 2017

Pasqualucci L

4

1 reference

20 September 2017

Lichter P

5

1 reference

20 September 2017

Döhner H

6

1 reference

20 September 2017

Stilgenbauer S

7

1 reference

20 September 2017

1 July 2005

1 reference

20 September 2017

1 reference

20 September 2017

19

1 reference

20 September 2017

1211-1215

1 reference

20 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403778

20 September 2017

0 references

cites work

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Functional evaluation of the role of inhibitor of apoptosis proteins in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Trisomy 12 in B-cell chronic lymphocytic leukemia: correlation with advanced disease, atypical morphology, high levels of sCD25, and with refractoriness to treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403778

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403778

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference